These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22819716)

  • 1. Detection and treatment of subclinical tuberculosis.
    Robertson BD; Altmann D; Barry C; Bishai B; Cole S; Dick T; Duncan K; Dye C; Ehrt S; Esmail H; Flynn J; Hafner R; Handley G; Hanekom W; van Helden P; Kaplan G; Kaufmann SH; Kim P; Lienhardt C; Mizrahi V; Rubin E; Schnappinger D; Sherman D; Thole J; Vandal O; Walzl G; Warner D; Wilkinson R; Young D
    Tuberculosis (Edinb); 2012 Nov; 92(6):447-52. PubMed ID: 22819716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis vaccines: hopes and hurdles.
    Ahsan MJ; Garg SK; Vashistha B; Sharma P
    Infect Disord Drug Targets; 2013 Oct; 13(5):318-21. PubMed ID: 24304353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in diagnosis and treatment of latent tuberculosis infection.
    Gupta KB
    Indian J Tuberc; 2012 Jan; 59(1):1-5. PubMed ID: 22670504
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and Management of Latent Tuberculosis Infection.
    Muñoz L; Stagg HR; Abubakar I
    Cold Spring Harb Perspect Med; 2015 Jun; 5(11):. PubMed ID: 26054858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis.
    Miyata T; Cheigh CI; Casali N; Goodridge A; Marjanovic O; Kendall LV; Riley LW
    Vaccine; 2012 Jan; 30(2):459-65. PubMed ID: 22079078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine strategies against latent tuberculosis infection.
    Andersen P
    Trends Microbiol; 2007 Jan; 15(1):7-13. PubMed ID: 17141504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis in Africa: learning from pathogenesis for biomarker identification.
    Kaufmann SH; Parida SK
    Cell Host Microbe; 2008 Sep; 4(3):219-28. PubMed ID: 18779048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions.
    Lienhardt C; Lönnroth K; Menzies D; Balasegaram M; Chakaya J; Cobelens F; Cohn J; Denkinger CM; Evans TG; Källenius G; Kaplan G; Kumar AM; Matthiessen L; Mgone CS; Mizrahi V; Mukadi YD; Nguyen VN; Nordström A; Sizemore CF; Spigelman M; Squire SB; Swaminathan S; Van Helden PD; Zumla A; Weyer K; Weil D; Raviglione M
    PLoS Med; 2016 Mar; 13(3):e1001965. PubMed ID: 26933883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present-day treatment of tuberculosis and latent tuberculosis infection.
    Pérez-Camacho I; Rivero-Juárez A; Kindelán JM; Rivero A
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():41-6. PubMed ID: 21420566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection.
    van Altena R; Duggirala S; Gröschel MI; van der Werf TS
    Curr Pharm Des; 2011; 17(27):2853-62. PubMed ID: 21834760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
    Khademi F; Derakhshan M; Yousefi-Avarvand A; Tafaghodi M; Soleimanpour S
    Expert Rev Vaccines; 2018 Jan; 17(1):31-44. PubMed ID: 29148853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass treatment to eliminate tuberculosis from an island population.
    Hill PC; Dye C; Viney K; Tabutoa K; Kienene T; Bissell K; Williams BG; Zachariah R; Marais BJ; Harries AD
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):899-904. PubMed ID: 25199002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis: an overview.
    Cruz-Knight W; Blake-Gumbs L
    Prim Care; 2013 Sep; 40(3):743-56. PubMed ID: 23958367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent Tuberculosis Infection.
    Shah M; Dorman SE
    N Engl J Med; 2021 Dec; 385(24):2271-2280. PubMed ID: 34879450
    [No Abstract]   [Full Text] [Related]  

  • 15. New potential biomarkers to assess efficacy of protection afforded by vaccine candidates against tuberculosis.
    Flores-Valdez MA
    Clin Microbiol Infect; 2019 Jun; 25(6):656-658. PubMed ID: 30797061
    [No Abstract]   [Full Text] [Related]  

  • 16. Focus on latent tuberculosis.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2016 Oct; 4(10):763. PubMed ID: 27707455
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in the diagnosis and treatment of latent tuberculosis infection.
    Jung YEG; Schluger NW
    Curr Opin Infect Dis; 2020 Apr; 33(2):166-172. PubMed ID: 32022744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.
    Warsinske HC; Rao AM; Moreira FMF; Santos PCP; Liu AB; Scott M; Malherbe ST; Ronacher K; Walzl G; Winter J; Sweeney TE; Croda J; Andrews JR; Khatri P
    JAMA Netw Open; 2018 Oct; 1(6):e183779. PubMed ID: 30646264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific features of tuberculosis in childhood].
    Delacourt C
    Rev Mal Respir; 2011 Apr; 28(4):529-41. PubMed ID: 21549907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent Mycobacterium tuberculosis infection.
    Getahun H; Matteelli A; Chaisson RE; Raviglione M
    N Engl J Med; 2015 May; 372(22):2127-35. PubMed ID: 26017823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.